BIOMAT Database Logo BIOMAT Database Logo

[Dynamics of complement-fixing antibodies in Q fever]. 1972

V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău

UI MeSH Term Description Entries
D011778 Q Fever An acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals (ANIMALS, DOMESTIC). Coxiella burnetii Fever,Query Fever,Acute Q Fever,Chronic Q Fever,Coxiella burnetii Infection,Coxiella burnetii Vector-Borne Disease,Acute Q Fevers,Chronic Q Fevers,Coxiella burnetii Fevers,Coxiella burnetii Infections,Coxiella burnetii Vector Borne Disease,Fever, Acute Q,Fever, Chronic Q,Fever, Coxiella burnetii,Fever, Q,Fever, Query,Fevers, Acute Q,Fevers, Chronic Q,Fevers, Coxiella burnetii,Fevers, Q,Fevers, Query,Infection, Coxiella burnetii,Infections, Coxiella burnetii,Q Fever, Acute,Q Fever, Chronic,Q Fevers,Q Fevers, Acute,Q Fevers, Chronic,Query Fevers
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013752 Tetracycline A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. 4-Epitetracycline,Achromycin,Achromycin V,Hostacyclin,Sustamycin,Tetrabid,Tetracycline Hydrochloride,Tetracycline Monohydrochloride,Topicycline,4 Epitetracycline
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
[Q fever; complement-fixing antibodies in the population of Cordoba (R.A.)].
January 1956, La Semana medica,
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
Studies on Q fever; persistence of complement-fixing antibodies after naturally acquired infection.
February 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
The persistence of complement-fixing antibodies to Q-fever (Coxiella burneti) after infection.
June 1970, The Medical journal of Australia,
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
Q fever complement fixing; antibodies in animal and human sera in the Middle East.
July 1954, Le Journal medical libanais. The Lebanese medical journal,
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
Studies on Q fever; complement-fixing antibodies in meat packers at Fort Worth, Texas.
February 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
[On the duration of retention of complement-fixing antibodies in patients recovering from Q-fever].
January 1966, Sovetskoe zdravookhranenie Kirgizii,
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
The presence of Q fever complement fixing antibodies in sear of inhabitants of the province of Quebec.
April 1952, Canadian Medical Association journal,
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
[Development and duration of complement fixing and agglutinating antibodies in treated and non-treated Q-fever patients].
January 1953, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Zweite naturwissenschaftliche Abt.: Allgemeine, landwirtschaftliche und technische Mikrobiologie,
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
Q fever studies. XV. Development and persistence in man of complement-fixing and agglutinating antibodies to Coxiella burnetii.
May 1952, Journal of immunology (Baltimore, Md. : 1950),
V T Buşilă, and I Vasilescu, and G Olaru, and M Vilceanu, and A Fitărău
Prevention of autoimmune diabetes through immunostimulation with Q fever complement-fixing antigen.
November 2003, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!